Latest Repros Therapeutics Inc. Stories

2014-09-29 08:29:53

NEW YORK, Sept. 29, 2014 /PRNewswire-USNewswire/ -- Androxal((R)) Second Pivotal Study from Repros Therapeutics Inc.

2008-11-10 18:00:05

Repros Therapeutics Inc. (NasdaqGM:RPRX) announced today that it has filed a Form S-3 shelf registration statement with the Securities and Exchange Commission for up to 6,282,052 shares of common stock. The Company has filed this shelf registration statement for two reasons.

2008-10-29 18:00:07

Repros Therapeutics Inc. (NasdaqGM:RPRX) announced today that the Company's President and CEO, Joseph Podolski, will present a corporate overview on Monday, November 3, 2008, at 2:00 p.m. Eastern Time during the Oppenheimer 19th Annual Healthcare Conference. Mr.

2008-10-02 21:00:23

Repros Therapeutics Inc. (NasdaqGM:RPRX) today announces that it has consummated its previously announced sale of an aggregate of 2.4 million shares of its common stock resulting in net proceeds to the Company of approximately $15.5 million after deduction of estimated offering expenses.

Word of the Day
  • A hairdresser.
The word 'friseur' comes from French friseur, from friser ("to curl, frizz").